At the conclusion of this educational activity, the participant should be able to:
1) Describe how NEMOS registry operates (countries involved, patients enrolled)
2) Explain how apheresis treatments were analyzed (1st, 2nd, 3rd line treatment) and used with other disease-modifying therapies.
3) Summarize key findings (remission rate was increased with apheresis initiation within 2 days).